Strategic Partnerships
Powering Precision Through Partnership
Empowering Healthcare Through Strategic Partnerships
We believe that meaningful innovation happens through collaboration. Our partnerships unite scientific excellence, clinical insight, and advanced technology to accelerate the shift toward personalized, value-based care. By aligning with industry leaders, we combine next-generation testing, data integration, and predictive analytics to deliver smarter medication decisions and measurable outcomes that improve lives.
We Are Partnered With The Best and Brightest Minds In The Industry
Precision Molecular
Precision Molecular develops advanced radiotherapeutic and imaging agents that unite diagnostics and therapy to advance precision oncology. Their technology enhances disease targeting and treatment accuracy, providing SmartDoseRx with vital molecular insight to link diagnostic data with clinical decision-making for improved therapeutic precision and patient outcomes.
ActX, Inc.
ACTX integrates actionable genomic data into clinical workflows through real-time, EHR-embedded decision support. Its platform enables prescribers to automatically assess drug efficacy, dosing, and adverse reaction risk. By powering SmartDoseRx with genomic intelligence, ACTX makes personalized medication management practical, data-driven, and scalable across healthcare systems.
Powering Precision Through Partnership
SmartDoseRx collaborates with innovators across healthcare, research, and technology to advance precision prescribing and deliver measurable impact. From research and real-world evidence to product development and precision analytics, our partners help turn data into smarter decisions and better outcomes.
Become a partner and help redefine what’s possible in personalized care.
Join Us in Transforming Patient Outcomes
Together, we can make every medication decision safer, smarter, and more effective, delivering better outcomes for patients and greater value for the healthcare system.